TECHNETIUM TC 99M EPRATUZUMAB Uses, Dosage, Side Effects and more
TECHNETIUM TC 99M EPRATUZUMAB is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).
Trade Name | TECHNETIUM TC 99M EPRATUZUMAB |
Generic | Technetium Tc-99m epratuzumab |
Technetium Tc-99m epratuzumab Other Names | TECHNETIUM TC 99M EPRATUZUMAB |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |